Evidence map›Paper›PMID 41082583›Full record

ArticlePLoS computational biology2025

Enhancing antibody-antigen interaction prediction with atomic flexibility.

Sara Joubbi, Alessio Micheli, Paolo Milazzo, Giorgio Ciano, Stéphane M Gagné, Pietro Liò, Duccio Medini, Giuseppe Maccari

Abstract read
In one paragraph

Article in PLoS computational biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Sara JoubbiDepartment of Computer Science, University of Pisa, Pisa, Italy.ORCID 0009-0002-1079-7204
Alessio MicheliDepartment of Computer Science, University of Pisa, Pisa, Italy.ORCID 0000-0001-5764-5238
Paolo MilazzoDepartment of Computer Science, University of Pisa, Pisa, Italy.
Giorgio CianoData Science for Health Lab, Fondazione Toscana Life Sciences, Siena, Italy.
Stéphane M GagnéDepartment of Biochemistry, Microbiology and Bioinformatics, Université Laval, Québec, Canada.
Pietro LiòDepartment of Computer Science and Technology, University of Cambridge, Cambridge, United Kingdom.
Duccio MediniData Science for Health Lab, Fondazione Toscana Life Sciences, Siena, Italy.
Giuseppe MaccariData Science for Health Lab, Fondazione Toscana Life Sciences, Siena, Italy.ORCID 0000-0002-2894-3583

Funding

European Union – Next Generation EUItalian Ministry of HealthItalian National Recovery and Resilience Plan (PNRR)
6 · The paper itself

Abstract

Antibodies are indispensable components of the immune system, known for their specific binding to antigens. Beyond their natural immunological functions, they are fundamental in developing vaccines and therapeutic interventions for infectious diseases. The complex architecture of antibodies, particularly their variable regions responsible for antigen recognition, presents significant challenges for computational modeling. Recent advancements in deep learning have markedly improved protein structure prediction; however, accurately modeling antibody-antigen (Ab-Ag) interactions remains challenging due to the inherent flexibility of antibodies and the dynamic nature of binding processes. In this study, we examine the use of predicted Local Distance Difference Test (pLDDT) scores as indicators of residue and side-chain flexibility to model Ab-Ag interactions through a fingerprint-based approach. We demonstrate the significance of flexibility in different antibody-specific tasks, enhancing the predictive accuracy of Ab-Ag interaction models by 4%, resulting in an AUC-ROC of 92%. In addition, we showcase state-of-the-art performance in paratope prediction. These results emphasize the importance of accounting for conformational flexibility in modeling antibody-antigen interactions and show that pLDDT can serve as a coarse proxy for these dynamic features. By optimizing antibody flexibility using pLDDT, they can be engineered to improve affinity or breadth for a specific target. This approach is particularly beneficial for addressing highly variable pathogens like HIV and SARS-CoV-2, as greater flexibility enhances tolerance to sequence variations in target antigens.

Indexed as

Antigen-Antibody ReactionsAntigensBinding Sites, AntibodyComputational BiologyCOVID-19Deep LearningHumansModels, MolecularProtein BindingProtein ConformationSARS-CoV-2Antigens

Identifiers

PMID41082583
PMCPMC12530544

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.